Chromatin Bioscience
Customised Gene Expression Systems
- Employees
- 1–10
- Business Model
- B2B
- Website
- chromatinbio.com
- Total Funding
- $150K
- Last Round
- $150K Grant
- Rounds
- 1
About
Chromatin Bioscience designs synthetic gene regulatory elements — including promoters and expression cassettes — using bioinformatics to mine genomic datasets. Their technology enables cell-selective, controllable gene expression for cell and gene therapies, biologics manufacturing, industrial biotech, and agricultural biotech. The company partners with pharma firms including Astellas and Purespring Therapeutics.
Summary
Chromatin Bioscience is a Biotech company. It has raised $150K in total across 1 round. Investors include Scottish Enterprise.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Unknown
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company